Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.
Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.
GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback